rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP
Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP
† Study has passed its completion date and status has not been verified in more than two years.